产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
A999284 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab), Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab), |
|||
A999285 | Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab), Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab), |
|||
A999286 | Anti-VEGFR3 / FLT4 Reference Antibody (LY3022856), Anti-VEGFR3 / FLT4 Reference Antibody (LY3022856), |
|||
A999287 | Anti-vWF Reference Antibody (Ajinomoto patent anti-vWF), Anti-vWF Reference Antibody (Ajinomoto patent anti-vWF), |
|||
A999288 | Anti-vWF Reference Antibody (INSERM patent anti-vWF), Anti-vWF Reference Antibody (INSERM patent anti-vWF), |
|||
P767805 | 101791-31-5 | mPEG7-CH2COOH, 95% mPEG7-CH2COOH, 95% |
C17H34O10 | |
N775965 | NUT (C52B1) Rabbit mAb, NUT (C52B1) Rabbit mAb, |
|||
767744 | 1260393-98-3 | 仑卡奈单抗, 98%, 100mg/mL in PBS Lecanemab, 98%, 100mg/mL in PBS |
||
768403 | 637334-45-3 | 奥克立珠单抗, 98% Ocrelizumab (anti-CD20), 98% |
||
767745 | 1572943-04-4 | 特折鲁单抗, 98% Tezepelumab, 98% |
||
768723 | 1384260-65-4 | 阿杜那单抗, 98% Aducanumab, 98% |